Undisclosed Microbiome Program(s)

About Intrinsic Medicine

Intrinsic Medicine is a private, preclinical-stage biotech leveraging the microbiome to create new treatments for chronic diseases. Operating from Seattle, the company is in the early stages of building its therapeutic pipeline, likely targeting mechanisms linking gut microbiota to systemic inflammation and metabolism. As a pre-revenue entity, its success hinges on advancing its platform science into clinical validation and securing strategic partnerships or funding to fuel development.

Therapeutic Areas